ROCKWELL MEDICAL, IN

RMTI
Delayed Quote. Delayed  - 10/20 04:00:00 pm
1.05USD -0.94%
Prev.1.0600
Open1.0800
High1.0800
Low1.0400
Volume783 928
Latest news
7d ago
7d ago
09/25
09/24
Chart ROCKWELL MEDICAL, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance1,351,681,93
Spread/Res.-22%-38%-46%
Spread/Supp.0,96%0,96%67%
Support1,041,040,63
Financials
Sales 2020 66,6 M - -
Net income 2020 -29,2 M - -
Net Debt 2020 - - -
P/E ratio 2020 -2,65x
Yield 2020 -
Capitalization 97,5 M 97,5 M -
Capi. / Sales 2020 1,46x
Capi. / Sales 2021 0,89x
Nbr of Employees 299
Free-Float 95,9%
Company
Rockwell Medical, Inc. is a biopharmaceutical company. The Company is targeting end-stage renal disease and chronic kidney disease with products for the treatment of iron deficiency and hemodialysis. The Company is also a manufacturer of hemodialysis concentrates for dialysis providers and...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-04 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 2
Average target price 7,00 $
Last Close Price 1,06 $
Spread / Highest target 749%
Spread / Average Target 560%
Spread / Lowest Target 372%